News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Asset Management

Wellcome Trust ‘actively planning’ for lower returns ahead

‘We do not expect the investment environment to get any easier’, says £27bn endowment

Doctor Jean-Jacques Muyembe Tamfun being inoculated with an Ebola vaccine in November. Research that produced the world's first licensed vaccine against the virulent disease was part-funded by the Wellcome Trust
Doctor Jean-Jacques Muyembe Tamfun being inoculated with an Ebola vaccine in November. Research that produced the world's first licensed vaccine against the virulent disease was part-funded by the Wellcome Trust Photo: Getty Images

The Wellcome Trust, one of the world’s wealthiest charitable foundations, is planning for its return on investments to fall in the years ahead, citing Brexit, a “protracted economic struggle” between the US and China, and political “logjam” in Europe.

The trust, which was founded by the will of British pharmaceutical magnate Sir Henry Wellcome in 1936 to fund medical research, said its investment portfolio grew to £26.8bn in the 12 months that ended on September 30, with a return of 6.9% — just over half what it was last year.

WSJ Logo